Episode 135: VTE Series - Management of Antiphospholipid Antibody Syndrome
The Fellow on Call: The Heme/Onc Podcast
00:00
Navigating Antiphospholipid Antibody Syndrome Treatment
This chapter explores the comparative effectiveness of apixaban and warfarin in treating Antiphospholipid Antibody Syndrome (APS), referencing the Astro-APS trial findings. It discusses the complexities of anticoagulation strategies, particularly the evolving roles of Direct Oral Anticoagulants (DOACs) and warfarin based on patient profiles. Additionally, the chapter emphasizes the implications of timely antibody testing and the necessity of personalized treatment approaches for patients with unprovoked blood clots.
Transcript
Play full episode
